HANGZHOU TIGERMED CO. H 1 Cash Flow Reinvestment Rate
HANGZHOU TIGERMED CO. H 1 cash flow reinvestment rate. HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Cash Flow Reinvestment Rate of 1.01x as of December 2025, reinvesting €1.13 Billion (capex €214.37 Million plus investments €914.13 Million) from operating cash flow of €1.12 Billion. Explore 5HZ1 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of HANGZHOU TIGERMED CO. H 1 (2021–2025)
Cash flow reinvestment rate of HANGZHOU TIGERMED CO. H 1 from 2021 to 2025. Historical reinvestment intensity for HANGZHOU TIGERMED CO. H 1 across 5 annual periods. Explore HANGZHOU TIGERMED CO. H 1 capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
HANGZHOU TIGERMED CO. H 1 Cash Flow Reinvestment Rate by Year (2021–2025)
HANGZHOU TIGERMED CO. H 1 cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for HANGZHOU TIGERMED CO. H 1. For the full cash flow conversion analysis, see HANGZHOU TIGERMED CO. H 1 operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | €1.13 Billion | €1.12 Billion | €214.37 Million | ▼ -74.7% |
| 2024 | 3.99x | €4.38 Billion | €1.10 Billion | €356.55 Million | ▲ +271.0% |
| 2023 | 1.08x | €1.24 Billion | €1.15 Billion | €313.76 Million | ▼ -34.2% |
| 2022 | 1.64x | €2.22 Billion | €1.36 Billion | €448.60 Million | ▼ -6.6% |
| 2021 | 1.75x | €2.49 Billion | €1.42 Billion | €368.62 Million | — |